Postthrombolytic Antiplatelet Use for Patients with Intercerebral Hemorrhage without Extensive Parenchymal Involvement Does Not Worsen Outcome

BACKGROUND AND PURPOSE: It is unclear whether postthrombolytic antiplatelet (AP) therapy after thrombolytic-related hemorrhage without extensive parenchymal involvement (THEPI) affects the clinical outcome. This study explored whether AP administration in patients with THEPI affects short- and long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Weihua, Zhou, Lichun, Liao, Xiaoling, Pan, Yuesong, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596115/
https://www.ncbi.nlm.nih.gov/pubmed/26424236
http://dx.doi.org/10.3988/jcn.2015.11.4.305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596115/
https://www.ncbi.nlm.nih.gov/pubmed/26424236
http://dx.doi.org/10.3988/jcn.2015.11.4.305

Ejemplares similares